ASCO EDITION 2011
BROUGHT TO YOU BY CURE MAGAZINE
Showing posts with label asco 2011. Show all posts
Showing posts with label asco 2011. Show all posts
Wednesday, July 13, 2011
Monday, July 04, 2011
Friday, June 17, 2011
(from asco 2011) video: Dr Steven Joffe – Dana-Farber Cancer Institute, Boston - Ethics of early-phase clinical trials on ecancer tv. Cancer journal: online cancer news, clinical oncology research, cancer information and latest cancer studies - open access cancer journal: ecancermedicalscience
Ethics of early-phase clinical trials
Dr Joffe talks to ecancer tv at ASCO 2011 about the arguments around
patient recruitment and expectation management in early-phase clinical
trials.Monday, June 13, 2011
Deals Of The Week: The ASCO Edition (blogger)
Deals Of The Week: The ASCO Edition: "
ASCO is just moving into full swing, but already the press releases are flying fast and furious. Biotechs have long looked to this meeting as a means to showcase their smarts and increase their profile with public investors. But as big pharmas have set their sights on oncology as the therapeutic area of choice -- given its high unmet medical need and, historically, generous reimbursement, there's no doubt ASCO is now a critical meeting for even the biggest players in the industry......cont'd
© Copyright 2007-2011 Windhover Information Inc.
www.windhover.com/blog
www.windhover.com/blog
"
Live From ASCO: Time To Cool Down? (see blogger's note on ovarian cancer)
Live From ASCO: Time To Cool Down?: "
It's day three of ASCO and the meeting is at a fever pitch, as the National Cancer Institute's Antonio Tito Fojo wryly observed during a panel on designing randomized controlled trials to achieve meaningful benefits. Not that it's an unusual state for the world's largest meeting on the largest field of drug development.
There is the typical fervor surrounding promising early data, a few major advances to report (for instance, the melanoma data from Roche and BMS covered by among others, the NYT, WSJ, Reuters, and, of course, 'The Pink Sheet' Daily), and the meeting halls are packed with clinicians, investors, and journos. (Saturday's clinical science symposium on ovarian cancer had such throngs waiting for it to start that McCormick Place called in bouncers, from 'Armageddon Security,' nonetheless. And if you weren't in the initial crush, you probably got diverted to an overflow room. Or the second overflow room.)
Still, compared to other years, analysts aren't finding much to write home about. And, increasingly, the importance of the data being presented before packed meeting halls is being questioned. 'We need to get away from things that add cost but not value,' UnitedHealthcare's Lee Newcomer noted during a panel on health care reform.................cont'd
Image courtesy of flickrer Joe Seggiola through a creative commons license.
There is the typical fervor surrounding promising early data, a few major advances to report (for instance, the melanoma data from Roche and BMS covered by among others, the NYT, WSJ, Reuters, and, of course, 'The Pink Sheet' Daily), and the meeting halls are packed with clinicians, investors, and journos. (Saturday's clinical science symposium on ovarian cancer had such throngs waiting for it to start that McCormick Place called in bouncers, from 'Armageddon Security,' nonetheless. And if you weren't in the initial crush, you probably got diverted to an overflow room. Or the second overflow room.)
Still, compared to other years, analysts aren't finding much to write home about. And, increasingly, the importance of the data being presented before packed meeting halls is being questioned. 'We need to get away from things that add cost but not value,' UnitedHealthcare's Lee Newcomer noted during a panel on health care reform.................cont'd
Image courtesy of flickrer Joe Seggiola through a creative commons license.
© Copyright 2007-2011 Windhover Information Inc.
www.windhover.com/blog
www.windhover.com/blog
"
Thursday, June 09, 2011
OCNA - webinar registration/Dr Deborah Armstrong **June 16th** Ovarian Cancer News from 2011 ASCO
Ovarian Cancer News from the 2011 ASCO Meeting
Thursday, June 16, 2011 1:00 PM - 2:00 PM EDT
Webinar Registration
More than 30,000 oncology professionals recently gathered in Chicago to share their latest research and findings at the American Society of Clinical Oncology Annual Meeting. We've sifted through the new data to bring you an update on studies that are relevant to women with ovarian cancer. Join us as Dr. Deborah Armstrong of The Johns Hopkins School of Medicine reviews the most important findings from the ASCO meeting and how they could affect women with ovarian cancer.Sunday, June 05, 2011
Subscribe to:
Posts
(
Atom
)
